2024-06-14 07:00:00 ET
Summary
- On Monday, June 10, I bought shares of five blue chips and sold two.
- British American Tobacco's fundamentals remain strong, with expected sales growth and potential for an upgrade in credit rating by 2027.
- I snapped up 100 more shares of NVDA at fair value because post-earnings sales forecasts for next year have doubled. And there's up to 100% FCF beat potential next year.
- Brookfield Asset Management is 10% undervalued. It's the king of fundraising and global infrastructure in a world that needs to spend $6 trillion per year on infrastructure.
- RSST and RSSY are return-stacking ETFs that combine the S&P with trend-following and yield futures, respectively.
Limit Buying Bonanza: 5 Blue-Chips I Just Bought And Two I Sold
Here's a summary of the limits that I filled the morning of Monday, June 10, since my readers seem most interested in what I'm doing with my own hard-earned money.
British American Tobacco ( BTI )
Trade Summary
- Shares purchased: 400 (then 200 more in a 2nd limit)
- Price: $31.25 (9.5% yield) ($30.64) (9.7% yield)
- Shares I Now Own: 6,066.4674
- Cost Basis: $30.08 (9.9% yield)
British American was a "fat finger" slip when I was entering the limit orders. I meant to set it at a lower price, but I'm still thrilled to have another 400 shares.
That's another $100 monthly dividend income (average), and BTI's fundamentals remain completely intact.
Sales are expected to rebound, set new records in 2025, and grow 3.5% annually through 2028.
That's above the 1% to 3% annual sales growth guidance management provided and reiterated at its June 5 trading update ....
Read the full article on Seeking Alpha
For further details see:
Limit Buying Bonanza: 5 Blue Chips I Just Bought And 2 I Sold